🔎 Trials Near Me

Hjem › Akut myelogen leukemi › Pennsylvania › Allentown

Kliniske studier for Akut myelogen leukemi i Allentown, PA

8 studier for Akut myelogen leukemi søker deltakere på steder i og rundt Allentown (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RekruttererFase 2
  • Lehigh Valley Hospital-Cedar Crest, Allentown
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT05564390

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem · 6 mi unna
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

RekruttererFase 2
  • Lehigh Valley Hospital-Cedar Crest, Allentown
Alder 18 til 59 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT05554393

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

RekruttererFase 2
  • Lehigh Valley Hospital-Cedar Crest, Allentown
Alder 18 til 59 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

RekruttererFase 2
  • Lehigh Valley Hospital-Cedar Crest, Allentown
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

RekruttererFase 3
  • Lehigh Valley Hospital-Cedar Crest, Allentown
6 Months – 21 Years · Alle kjønn · Oppdatert 17. sep. 2026 · NCT04293562

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

RekruttererFase 2
  • Spoknwrd Clinical Trials Inc., Easton · 15 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT06824168

Akut myelogen leukemi-studier i andre byer

Andre studier i Allentown

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.